Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma

Data sharing statement

Requests for anonymized patient data will be examined on an individual basis by relevant administrating committees of the Colcheckpoint and BIONIKK cohorts data. Processed data from animal experiments are available on request from the corresponding authors.